Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02646033 |
|
Recruitment Status :
Completed
First Posted : January 5, 2016
Last Update Posted : March 17, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Intraocular Pressure |
| Study Type : | Observational |
| Actual Enrollment : | 100 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position |
| Actual Study Start Date : | September 2016 |
| Actual Primary Completion Date : | September 2018 |
| Actual Study Completion Date : | April 2019 |
| Group/Cohort |
|---|
|
robotic surgery
all those patients aged 40 - 60 years undergoing robotic surgeries, who does not have any ophthalmic complains.
|
- Intraocular pressure [ Time Frame: 7-8 months ]change in pressure with the position during surgery
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 40 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- American Society of Anaesthesiologists (ASA) status 1-3
- without any ophthalmic complains or interventions
Exclusion Criteria:
- lasix given during preoperative or intraoperative period
- cardiac patients who are on medications for stents or post Coronary Artery Bypass Graft (CABG)
- pre-existing glaucoma, eye surgeries, cataract or retinal vascular diseases, corneal diseases which may affect IOP measurement were excluded
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02646033
| India | |
| Rajiv Gandhi Cancer Institute & Research Centre | |
| New Delhi, Delhi, India, 110085 | |
| Principal Investigator: | Nitesh Goel, MBBS,DA, DNB | Rajiv Gandhi Cancer Institute & Research Centre |
| Responsible Party: | Dr. Nitesh Goel, Doctor, Consultant Anaesthesia, Rajiv Gandhi Cancer Institute & Research Center, India |
| ClinicalTrials.gov Identifier: | NCT02646033 |
| Other Study ID Numbers: |
RajivGCIRC |
| First Posted: | January 5, 2016 Key Record Dates |
| Last Update Posted: | March 17, 2020 |
| Last Verified: | March 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Intraocular Pressure, Trendelenburg position |

